Nassir F. Marrouche, MD | Tulane School ...

Dr. Nassir Marrouche, MD

Claim this profile

Tulane University Medical Center

Studies Atrial Fibrillation
Studies Stroke
9 reported clinical trials
10 drugs studied

Affiliated Hospitals

Image of trial facility.

Tulane University Medical Center

Image of trial facility.

University Medical Center New Orleans

Clinical Trials Nassir Marrouche, MD is currently running

Image of trial facility.

Coagulation Biomarkers

for Atrial Fibrillation

The aim of the Correlation Of CoAGulation-Atrial Fibrillation (COAG-AF) study is to prove that an increase in pro-thrombotic biomarkers in AF is associated with an increase in AF burden. Secondary objectives of the study are the following: * To investigate the impact of catheter ablation on serum pro-thrombotic biomarkers in patients with AF. * To correlate coagulation biomarkers with imaging features such as, the degree of fibrosis found on Late Gadolinium Enhancement Magnetic Resonance Imaging (LGE-MRI) scans, which is a part of standard of care. * To determine baseline values of coagulation and pro-thrombotic biomarkers in the AF population and compare those baseline values with the general population values. * To compare central and peripheral thrombotic biomarkers in patients with atrial fibrillation.

Recruiting

1 award

N/A

4 criteria

Image of trial facility.

Baseline Atrial Fibrosis

for Predicting Post-Operative Atrial Fibrillation

The study aims to evaluate and compare the incidence of atrial arrhythmias (including Post-Operative Atrial Fibrillation (POAF), atrial flutter, and atrial tachycardia) stratified by baseline Utah fibrosis stages and overall fibrosis (%) of the left atrial wall area. The investigators hypothesize that patients with a higher baseline Utah fibrosis staging will experience a higher incidence of POAF. The study also aims to evaluate and compare the in-hospital mortality, length-of-stay (LOS), complication rates (strokes, pneumonia, respiratory failure etc.) of the different Utah fibrosis stage cohorts. Perform cost analysis and compare between patients with POAF and patients without POAF. The investigators hypothesize that patients experiencing POAF will have a higher mortality rate, longer LOS, greater complications, and therefore, additional hospital costs.

Recruiting

1 award

N/A

2 criteria

More about Nassir Marrouche, MD

Clinical Trial Related

5 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 5 Active Clinical Trials

Treatments Nassir Marrouche, MD has experience with

  • Cardiac And Brain MRI
  • Cardiac Surgery
  • Boston Scientific Cardiac Cryoablation System
  • POLARx™ Cardiac Cryoablation System
  • Wearable Health Monitoring Technology
  • Photoplethysmography

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Nassir Marrouche, MD specialize in?

Is Nassir Marrouche, MD currently recruiting for clinical trials?

Are there any treatments that Nassir Marrouche, MD has studied deeply?

What is the best way to schedule an appointment with Nassir Marrouche, MD?

What is the office address of Nassir Marrouche, MD?

Is there any support for travel costs?